Scholar Rock Holding Corp. (SRRK)
49.08
-0.47
(-0.95%)
USD |
NASDAQ |
Apr 15, 15:19
Scholar Rock Research and Development Expense (Annual) : 206.78M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Krystal Biotech, Inc. | 52.32M |
| Stoke Therapeutics, Inc. | 136.15M |
| Biogen, Inc. | 1.481B |
| Eli Lilly & Co. | 13.34B |
| Apellis Pharmaceuticals, Inc. | 295.85M |